{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:29:11Z","timestamp":1784654951792,"version":"3.55.0"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00c3\u00aancias e da Tecnologia","doi-asserted-by":"publisher","award":["006\/2015\/AMJ"],"award-info":[{"award-number":["006\/2015\/AMJ"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00c3\u00aancias e da Tecnologia","doi-asserted-by":"publisher","award":["003\/2017\/A1"],"award-info":[{"award-number":["003\/2017\/A1"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.01115","type":"journal-article","created":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:40:09Z","timestamp":1540514409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Baicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2"],"prefix":"10.3389","volume":"9","author":[{"given":"Peng","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Wen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Xiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,10,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ijpharm.2006.09.056","article-title":"Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.","volume":"332","author":"Agarwal","year":"2007","journal-title":"Int. J. Pharm."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/j.biopha.2017.07.068","article-title":"Baicalein: a review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma.","volume":"93","author":"Bie","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B3","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2174\/1871520611009030186","article-title":"Silibinin\u2013a promising new treatment for cancer.","volume":"10","author":"Cheung","year":"2010","journal-title":"Anticancer Agents Med. Chem."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S1734-1140(11)70624-7","article-title":"Effects of the antioxidant baicalein on the pharmacokinetics of nimodipine in rats: a possible role of P-glycoprotein and CYP3A4 inhibition by baicalein.","volume":"63","author":"Cho","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1158\/0008-5472.CAN-04-4662","article-title":"Milk thistle and prostate cancer: differential effects of pure flavonolignans from Silybum marianum on antiproliferative end points in human prostate carcinoma cells.","volume":"65","author":"Davis-Searles","year":"2005","journal-title":"Cancer Res."},{"key":"B6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1001\/jama.2012.8265","article-title":"Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial.","volume":"308","author":"Fried","year":"2012","journal-title":"JAMA"},{"key":"B7","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2174\/092986707779941159","article-title":"Silybin and silymarin\u2013new and emerging applications in medicine.","volume":"14","author":"Gazak","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development.","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"B9","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2015011592","article-title":"Polymeric drug-delivery systems: role in P-gp efflux system inhibition.","volume":"32","author":"Gupta","year":"2015","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"B10","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/S0002-9343(02)01244-5","article-title":"Milk thistle for the treatment of liver disease: a systematic review and meta-analysis.","volume":"113","author":"Jacobs","year":"2002","journal-title":"Am. J. Med."},{"key":"B11","first-page":"239","article-title":"Reassessing bioavailability of silymarin.","volume":"16","author":"Javed","year":"2011","journal-title":"Altern. Med. Rev."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1002\/ptr.5477","article-title":"Multiple ABC transporters efflux baicalin.","volume":"29","author":"Kalapos-Kovacs","year":"2015","journal-title":"Phytother. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1248\/bpb.28.2274","article-title":"Structure-activity relationships of the inhibitory effects of flavonoids on P-glycoprotein-mediated transport in KB-C2 cells.","volume":"28","author":"Kitagawa","year":"2005","journal-title":"Biol. Pharm. Bull."},{"key":"B14","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1124\/pr.113.007518","article-title":"Transporters and drug-drug interactions: important determinants of drug disposition and effects.","volume":"65","author":"Konig","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0021-9673(02)01971-4","article-title":"Analysis of the active components of silymarin.","volume":"990","author":"Kvasnicka","year":"2003","journal-title":"J. Chromatogr. A"},{"key":"B16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1211\/002235702522","article-title":"Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats.","volume":"55","author":"Lai","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1208\/s12248-011-9310-9","article-title":"Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae.","volume":"14","author":"Li","year":"2012","journal-title":"AAPS J."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/j.1471-4159.2009.06561.x","article-title":"Neuroprotection by baicalein in ischemic brain injury involves PTEN\/AKT pathway.","volume":"112","author":"Liu","year":"2010","journal-title":"J. Neurochem."},{"key":"B19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0090-9556(24)15299-3","article-title":"Correlation of biliary excretion in sandwich-cultured rat hepatocytes and in vivo in rats.","volume":"27","author":"Liu","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.3748\/wjg.v17.i18.2288","article-title":"Silybin and the liver: from basic research to clinical practice.","volume":"17","author":"Loguercio","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.2174\/138945011795378504","article-title":"ABC multidrug transporters: target for modulation of drug pharmacokinetics and drug-drug interactions.","volume":"12","author":"Marquez","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1124\/dmd.108.021790","article-title":"Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2).","volume":"36","author":"Miranda","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"B23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-3-319-41342-6_2","article-title":"Silymarin and its role in chronic diseases.","volume":"929","author":"Neha","year":"2016","journal-title":"Adv. Exp. Med. Biol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4103\/0976-500X.72350","article-title":"Blood sample collection in small laboratory animals.","volume":"1","author":"Parasuraman","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"key":"B25","first-page":"491","article-title":"Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.","volume":"124","author":"Pradhan","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview.","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.biopha.2017.08.135","article-title":"Baicalein as a potent neuroprotective agent: a review.","volume":"95","author":"Sowndhararajan","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"B28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/00498251003663724","article-title":"Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives.","volume":"40","author":"Srinivas","year":"2010","journal-title":"Xenobiotica"},{"key":"B29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3109\/03602530903491881","article-title":"Sandwich-cultured hepatocytes: an in vitro model to evaluate hepatobiliary transporter-based drug interactions and hepatotoxicity.","volume":"42","author":"Swift","year":"2010","journal-title":"Drug Metab. Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11101-013-9285-5","article-title":"Bioavailability of silymarin flavonolignans: drug formulations and biotransformation.","volume":"13","author":"Theodosiou","year":"2014","journal-title":"Phytochem. Rev."},{"key":"B31","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4254\/wjh.v6.i3.144","article-title":"Hepatoprotective effect of silymarin.","volume":"6","author":"Vargas-Mendoza","year":"2014","journal-title":"World J. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cgh.2006.10.014","article-title":"Complementary and alternative medicine in hepatology: review of the evidence of efficacy.","volume":"5","author":"Verma","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1124\/dmd.107.017566","article-title":"Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract.","volume":"36","author":"Wen","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"B34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cardiores.2004.09.027","article-title":"Baicalein protects rat cardiomyocytes from hypoxia\/reoxygenation damage via a prooxidant mechanism.","volume":"65","author":"Woo","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/molecules22010142","article-title":"Role of UDP-Glucuronosyltransferase 1A1 in the metabolism and pharmacokinetics of silymarin flavonolignans in patients with HCV and NAFLD.","volume":"22","author":"Xie","year":"2017","journal-title":"Molecules"},{"key":"B36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.phrs.2017.09.019","article-title":"Role of tangeretin as a potential bioavailability enhancer for silybin: pharmacokinetic and pharmacological studies.","volume":"128","author":"Yuan","year":"2017","journal-title":"Pharmacol. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ejps.2007.04.001","article-title":"Mechanistic study on the intestinal absorption and disposition of baicalein.","volume":"31","author":"Zhang","year":"2007","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:53:29Z","timestamp":1775253209000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2018.01115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,26]]},"references-count":37,"alternative-id":["10.3389\/fphar.2018.01115"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.01115","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,26]]},"article-number":"1115"}}